本文選題：長鏈非編碼RNA　切入點(diǎn)：骨肉瘤　出處：《華中科技大學(xué)學(xué)報(bào)(醫(yī)學(xué)版)》2017年06期

【摘要】：正骨肉瘤(Osteosarcoma,OS)是青少年最常見的原發(fā)性惡性骨腫瘤,年發(fā)病率為(1~4)/100萬,男女發(fā)病率之比為1.22∶1~([1])。骨肉瘤患者預(yù)后極差,目前我國骨肉瘤患者的5年生存率為37.5%~77.6%,而治療后復(fù)發(fā)、肺部轉(zhuǎn)移的患者,其平均生存時間更是不超過1年~([2-3])。因此,為提高骨肉瘤患者的診治率及改善預(yù)后,進(jìn)一步探究骨肉瘤發(fā)病分
[Abstract]:Osteosarcoma Osteosarcoma (Osteosarcoma) is the most common primary malignant bone tumor in adolescents. The annual incidence rate of Osteosarcoma Osteosarcoma (Osteosarcoma) is 1 / 1 million, and the ratio between male and female is 1. 22: 1.The prognosis of osteosarcoma patients is very poor. At present, the 5-year survival rate of osteosarcoma patients in China is 37.5% or 77.6%, and the average survival time of patients with recurrent and pulmonary metastasis after treatment is less than 1 year ([2-3]).Therefore, in order to improve the diagnosis and treatment rate of osteosarcoma and improve the prognosis of osteosarcoma, to further explore the incidence of osteosarcoma
【作者單位】： 華中科技大學(xué)同濟(jì)醫(yī)學(xué)院附屬協(xié)和醫(yī)院骨科;
【分類號】：R738.1
，

本文編號：1729004